|
US2010038369A1
|
|
Box for transporting samples
|
|
EP2026772A1
|
|
Nanoparticles of chitosan and hyaluronan for the administration of active molecules
|
|
CN101426479A
|
|
Stable nanocapsule systems for the administration of active molecules
|
|
EP1859792A1
|
|
Nanoparticles of chitosan and hyaluronan for the administration of active molecules
|
|
EP1774971A1
|
|
Chitosan and heparin nanoparticles
|
|
ES2259914A1
|
|
NANOPARTICULAS OF QUITOSANO AND POLYETHYLENE GLYCOL AS A SYSTEM OF ADMINISTRATION OF BIOLOGICALLY ACTIVE MOLECULES.
|
|
CA2553995A1
|
|
Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
|
|
ES2232287A1
|
|
POLYOXYETHYLATE DERIVATIVES NANOPARTICLES.
|
|
ES2222093A1
|
|
Method of storing and/or transporting in vitro cell cultures
|
|
NZ535850A
|
|
Novel therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine)
|
|
ES2222782A1
|
|
METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF PLAYING IN VITRO THE METABOLIC IDIOSINCRASIA OF HUMAN BEINGS.
|
